Key Insights

Highlights

Success Rate

86% trial completion

Published Results

17 trials with published results (17%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.8%

8 terminated out of 102 trials

Success Rate

86.2%

-0.4% vs benchmark

Late-Stage Pipeline

10%

10 trials in Phase 3/4

Results Transparency

34%

17 of 50 completed with results

Key Signals

17 with results86% success

Data Visualizations

Phase Distribution

88Total
Not Applicable (45)
Early P 1 (3)
P 1 (13)
P 2 (17)
P 3 (7)
P 4 (3)

Trial Status

Completed50
Unknown19
Recruiting11
Terminated8
Not Yet Recruiting5
Withdrawn4

Trial Success Rate

86.2%

Benchmark: 86.6%

Based on 50 completed trials

Clinical Trials (102)

Showing 20 of 20 trials
NCT04721548Phase 3CompletedPrimary

Treatment of Androgenetic Alopecia in Men for 24 Weeks

NCT07809191Not ApplicableNot Yet Recruiting

Hair Regrowth Following Partial Thickness Removal of SSCIS

NCT05723198Phase 3Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

NCT07783113Not ApplicableNot Yet RecruitingPrimary

Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

NCT07474558Phase 2Not Yet Recruiting

SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates

NCT07733063Recruiting

Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata

NCT05213936Not ApplicableRecruitingPrimary

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

NCT07271212Not ApplicableCompleted

Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir

NCT07228156Not ApplicableActive Not Recruiting

Study to Evaluate Xtresse Serum in Individuals With Thinning Hair

NCT07615608Not ApplicableCompleted

THERAVEX® REGENERA Tissue Care Plus for Hair Regeneration and Follicular Microenvironment Modulation

NCT04492800Not ApplicableCompletedPrimary

Hair Loss Prevention Study for Pancreatic Cancer

NCT04764357Not ApplicableRecruitingPrimary

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

NCT06215469Not ApplicableActive Not Recruiting

Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

NCT06999408Not ApplicableActive Not Recruiting

Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning

NCT03382184Not ApplicableTerminatedPrimary

Fractional Photothermolysis for Hair Follicle Induction

NCT07428954Completed

Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care

NCT07422376Not ApplicableRecruitingPrimary

Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region

NCT05778825Phase 2Active Not Recruiting

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

NCT07107841Not ApplicableRecruiting

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

NCT05544448Not ApplicableCompleted

In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases

Scroll to load more

Research Network

Activity Timeline